Cargando…
Novel insights on gut microbiota manipulation and immune checkpoint inhibition in cancer (Review)
Cancer affects millions of individuals worldwide. Thus, there is an increased need for the development of novel effective therapeutic approaches. Tumorigenesis is often coupled with immunosuppression which defeats the anticancer immune defense mechanisms activated by the host. Novel anticancer thera...
Autores principales: | Vivarelli, Silvia, Falzone, Luca, Leonardi, Giulia Costanza, Salmeri, Mario, Libra, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360620/ https://www.ncbi.nlm.nih.gov/pubmed/34396439 http://dx.doi.org/10.3892/ijo.2021.5255 |
Ejemplares similares
-
Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer
por: Leone, Gian Marco, et al.
Publicado: (2023) -
Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial?
por: Vivarelli, Silvia, et al.
Publicado: (2020) -
Gut Microbiota and Cancer: From Pathogenesis to Therapy
por: Vivarelli, Silvia, et al.
Publicado: (2019) -
Immune-checkpoint inhibitors from cancer to COVID-19: A promising avenue for the treatment of patients with COVID-19 (Review)
por: Vivarelli, Silvia, et al.
Publicado: (2020) -
Patient-Derived Tumor Organoids for Drug Repositioning in Cancer Care: A Promising Approach in the Era of Tailored Treatment
por: Vivarelli, Silvia, et al.
Publicado: (2020)